Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants von Pirttiaho, H I, Sotaniemi, E A, Pelkonen, R O, Pitkänen, U

Volltext

Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes von LUOMA, P. V, SOTANIEMI, E. A, PELKONEN, R. O, PIRTTIAHO, H. I

Volltext

Alcohol, HDL cholesterol, and liver microsomal induction von Luoma, P V, Sotaniemi, E A, Pelkonen, R O

Volltext

Drug metabolism in diabetic subjects with fatty livers von Pirttiaho, HI, Salmela, PI, Sotaniemi, EA, Pelkonen, RO, Pitkanen, U, Luoma, PV

Volltext

Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment von Luoma, P. V., Sotaniemi, E. A., Pelkonen, R. O., Myllylä, V. V.

Volltext

Relationship between lipid composition and drug metabolizing capacity of human liver von SAVOLAINEN, M. J, ARRANTO, A. J, HASSINEN, I. E, LUOMA, P. V, PELKONEN, R. O, SOTANIEMI, E. A

Volltext

Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver von Luoma, P V, Sotaniemi, E A, Pelkonen, R O, Arranto, A, Ehnholm, C

Volltext

Induction and lipoproteins von Luoma, P V, Sotaniemi, E A, Pelkonen, R O, Savolainen, M J, Ehnholm, C

Volltext

Effect of Liver Function on β-Blocker Kinetics von Sotaniemi, Eero A., Pelkonen, R. Olavi, Arranto, Arno J., Säkö, Sakari, Anttila, Markku

Volltext

Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol von Pirttiaho, HI, Sotaniemi, EA, Pelkonen, RO, Pitkanen, U, Anttila, M, Sundqvist, H

Volltext

Drug metabolism in epileptics: in vivo and in vitro correlations von Sotaniemi, EA, Pelkonen, RO, Ahokas, J, Pirttiaho, HI, Ahlqvist, J

Volltext

Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage von Sotaniemi, E A, Hokkanen, O T, Ahokas, J T, Pelkonen, R O, Ahlqvist, J

Volltext

Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period von Arvela, P., Kärki, N. T., Pelkonen, R. O.

Volltext

Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach von Rahnasto, M, Wittekindt, C, Juvonen, R O, Turpeinen, M, Petsalo, A, Pelkonen, O, Poso, A, Stahl, G, Höltje, H-D, Raunio, H

Volltext

Interaction of Aflatoxin B 1 with Cytochrome P450 2A5 and Its Mutants:  Correlation with Metabolic Activation and Toxicity von Pelkonen, Päivi, Lang, Matti A., Negishi, Masahiko, Wild, Christopher P., Juvonen, Risto O.

Volltext

The role of CYP enzymes in cocaine-induced liver damage von PASANEN, M, PELLINEN, P, STENBÄCK, F, JUVONEN, R. O, RAUNIO, H, PELKONEN, O

Volltext

Interaction of aflatoxin B sub(1) with cytochrome P450 2A5 and its mutants: Correlation with metabolic activation and toxicity von Pelkonen, P, Lang, MA, Negishi, M, Wild, C P, Juvonen, RO

Volltext